Clinical observation of Xiaoluowan(Ⅱ)in treating epididymitis

ZHOU Yu-chu; HUANG Wei-zhou; SHANG Xue-jun

doi:10.13263/j.cnki.nja.2023.05.010

Abstract：Objective:To observe the clinical efficacy of Xiaoluowan(Ⅱ)on epididymitis.Methods:61 patients with epi-didymitis were divided into two groups,acute group(23 cases)and non-acute group(38 cases).Both groups of patients were treated with Xiaoluowan(Ⅱ)6g twice a day orally,while acute group patients were given antibiotics intravenously.The treatment period is 4 weeks.The acute group evaluates the therapeutic efficacy comprehensively based on changes in clinical symptoms and signs,while re-cording changes in visual pain score(VAS).Chronic epididymitis symptom index(CESI)was used to evaluate the clinical symptoms before and after treatment in the non-acute group,and the curative efficacy was evaluated.Results:After treatment,the VAS scores in the acute group decreased from 7.08±1.09 to 2.10±1.37(P＜0.05).Total efficiency is 82.60％.In the non-acute group,the scores of pain before and after treatment were 7.08±1.09 and 2.10±1.37,the scores of quality of life were 7.28±1.14 and 1.87±1.56,the total scores were 14.37±1.78 and 3.97±2.73,respectively.The difference was significant(P＜0.05).Total efficiency is 84.21％.Conclusion:Xiaoluowan(Ⅱ)is an effective method to treat epididymitis and an effective supplement to modern medicine.